首页|鼓室注射糖皮质激素和高压氧治疗对特发性突发性感音神经性耳聋的疗效

鼓室注射糖皮质激素和高压氧治疗对特发性突发性感音神经性耳聋的疗效

扫码查看
目的 本研究旨在探究鼓室注射糖皮质激素(ITS)和高压氧治疗(HBOT)对全身糖皮质激素(SS)治疗失败的特发性突发性感音神经性耳聋(ISSNHL)患者的临床疗效。方法 回顾性收集 2020 年 1 月至 2023 年 1 月杭州市临平区第一人民医院耳鼻喉科收治的ISSNHL患者。根据治疗方案,ISSNHL患者分为SS组、HBOT组和ITS组。观察并比较治疗前(T0)、治疗第 5 天(T1)、治疗 3 个月后(T2)ISSNHL患者的听力水平[纯音听阈均值(PTA)]和听力增益改变,比较不同组别治疗总有效率。采用单因素分析探索不同治疗方式ISSNHL患者疗效的影响因素。结果 共纳入156例ISSNHL患者,SS组 70 例、HBOT组 33 例和ITS组 53 例。T0 时,3 组患者在PTA上差异无统计学意义(P>0。05)。T2 时,3组ISSNHL患者PTA水平较治疗前显著下降(P<0。05);HBOT组和ITS组PTA水平显著低于SS组(P<0。05);HBOT组PTA水平显著低于ITS组(P<0。05)。HBOT组和ITS组听力增益显著高于SS组(P<0。05),HBOT组听力增益显著高于ITS组(P<0。05)。HBOT组治疗总有效率显著高于ITS组(P<0。05),ITS组治疗总有效率显著高于SS组(P<0。05)。此外,无论何种治疗方案,眩晕均是ISSNHL患者听力恢复不良的影响因素(P<0。05)。结论 ITS和HBOT均可提升SS治疗失败ISSNHL患者的治疗有效率,促进ISSNHL听力恢复。较IST而言,HBOT疗效更为显著,建议临床治疗优先考虑。眩晕均是SS治疗失败ISSNHL患者听力恢复不良的影响因素,应在临床实践中重点关注。
The effectiveness of salvage treatment with intratympanic dexamethasone or hyperbaric oxygen therapy in addition to systemic steroids on idiopathic sudden sensorineural hearing loss
Objective To investigate the clinical efficacy of intratympanic corticosteroids(ITS)and hyperbaric oxygen therapy(HBOT)in patients with idiopathic sudden sensorineural hearing loss(ISSNHL)who had failed systemic corticosteroid(SS)treatment.Methods ISSNHL patients admitted to the Department of Otolaryngology,First People's Hospital of Linping District of Hangzhou city from January 2020 to January 2023 were retrospectively collected.According to the treatment plan,patients with ISSNHL were divided into SS group,HBOT group,and ITS group.The changes in hearing level[purity hearing threshold mean(PTA)]and hearing gain of ISSNHL patients before treatment(T0),day 5(T1)and after 3 months of treatment(T2)were observed and compared,and the total effective rate of treatment in different groups was compared.Univariate analysis was used to explore the influencing factors of the efficacy of patients with different treatment modalities of ISSNHL.Results A total of 156 ISSNHL patients were included,including 70 in the SS group,33 in the HBOT group and 53 in the ITS group.At T0,there was no significant difference in PTA among the three groups of patients(P>0.05).At T2,the level of PTA in the three groups of ISSNHL patients was significantly lower than that before treatment(P<0.05).The levels of PTA in the HBOT group and ITS group were significantly lower than those in the SS group(P<0.05).The level of PTA in the HBOT group was significantly lower than that in the ITS group(P<0.05).The hearing gain of the HBOT group and the ITS group was significantly higher than that of the SS group(P<0.05),and the hearing gain of the HBOT group was significantly higher than that of the ITS group(P<0.05).The total effective rate of HBOT group was significantly higher than that of ITS group(P<0.05),and the total effective rate of ITS group was significantly higher than that of SS group(P<0.05).In addition,vertigo was an influencing factor for poor hearing recovery in ISSNHL patients regardless of treatment regimen(P<0.05).Conclusion Both ITS and HBOT can improve the treatment efficiency of ISSNHL patients who have failed SS treatment and promote hearing recovery in ISSNHL.Compared with IST,HBOT has more significant efficacy,and it is recommended that clinical treatment be prioritized.Vertigo is an influencing factor for poor hearing recovery in patients with ISSNHL who have failed SS treatment,and should be focused on in clinical practice.

Idiopathic sudden sensorineural hearing lossIntratympanic steroidsHyperbaric oxygen therapy

金开林、赵琴、黄应亮

展开 >

杭州市临平区第一人民医院耳鼻咽喉科(杭州 311100)

杭州市西溪医院耳鼻咽喉科(杭州 311100)

特发性突发性感音神经性耳聋 鼓室注射糖皮质激素 高压氧治疗

杭州市卫生科技计划一般(B)类项目

B20231860

2024

中国药师
国家药品监督管理局高级研修学院,武汉医药(集团)股份有限公司

中国药师

CSTPCD
影响因子:0.944
ISSN:1008-049X
年,卷(期):2024.27(2)
  • 1
  • 18